Page 65 - IJB-3-1
P. 65

3D bioprinting of stem cells and polymer/bioactive glass composite scaffolds for bone tissue engineering

            tion  because  of  its good  rheological  and  viscoelastic   Fine cracks on the filament surface which are a couple
            properties. Despite its slow degradation rate (~2 years   of  microns  wide  and  up  to  ten  microns  or  more  in
            depending  on  the  molecular  weight),  PCL  has  been   length  can  be  observed  in  Figure 7C.  Those  cracks
            widely used to fabricate scaffolds for bone tissue en-  are believed to aid glass dissolution when the scaffold
            gineering [33] . But for other tissue engineering applica-  is immersed in the culture medium.
            tions  which  require  faster  degrading  of  scaffolding   Our degradation results also show a controlled re-
            structure,  this  may  become  an  impediment.  Since   lease  of  13-93B3  glass  over  a  period  of  two  weeks
            FDM  fabricated  polymer  scaffolds  are  only  biocom-  into  the  surrounding  solution.  In  the  past,  composite
            patible, another issue would be to make the scaffold-  thin films have been made using PCL/13-93B3 glass
            ing  structure  bioactive  by  incorporating  bioceramic   and  PCL/45S5  glass  with  different  amount  of  glass
            materials. In the past, some researchers made a poly-  content [35] .  The  degradation  data  of  such  thin  films
            mer-bioactive glass wire for use by the FDM process   indicate  that  the  entire  glass  almost  completely  dis-
            to  fabricate  polymer-bioactive  glass  scaffolds [34] .   solves in about three days. The graph shown in Figure
            However,  no  significant  improvement  in  bioactivity   8  compares  the  weight  loss  percentage  of  the
            and cell growth has been reported, which could be due   PCL/13-93B3 glass thin films (80 µm) with that of the
            to  inadequate  ionic  dissolution  of  the  glass  into  the   current  study.  Almost  entire  13-93B3  glass  was
            surrounding  environment.  This  makes  the  FDM  and   reacted  in  about  3 da ys  from  thin  films.  The  faster
            melt-deposition options unattractive for fabrication of   degradation  in  composite  films  could  be  due  to  the
            polymer-glass  composite  scaffolds.  In  our  current   thickness  of  the  film.  The  scaffolds  in  the  current
            study,  polymer  (PCL)  was  dissolved  in  a s olvent   study are made by filaments which are about 400 µm
            (chloroform), mixed with a bioactive glass (13-93B3   in diameter and have no surface pores that explained
            glass), and then extruded to fabricate the scaffold. Our   the very little glass dissolution in three days. However,
            weight loss results showed that most of the 13-93B3   the water absorbing potential of polymers in general
            glass  has  reacted in  2  weeks.  The  schematic  in  Fig-  was  reportedly  found  to  improve  after  the  addition
            ure 7 explains the difference in the glass dissolution   of bioceramic filler materials such as HA and even bio-
            from filaments printed using (A) FDM or melt-extrus-  active glass [12] . In our study, the glass dissolution in-
            ion  process  and  (B)  solvent-based  extrusion  process.   creased  significantly  after  7  and  14  days,  which  is
































            Figure 7. Schematic highlighting the difference in two methods of extrusion printing. (A) Melt-deposition of polymer-glass compo-
            site resulting in a dense filament and low bioactivity, (B) solvent-based extrusion printed composite resulting in a porous filament
            with high bioactivity, (C) SEM images showing surface cracks on the filament indicated by arrows in (i) and (ii), and pores inside the
            filament measuring less than 10 µm are also indicated by arrows in (iii).
                                        International Journal of Bioprinting (2017)–Volume 3, Issue 1      61
   60   61   62   63   64   65   66   67   68   69   70